Abstract
The mycology laboratory plays a vital role in the diagnosis of fungal infections through the recovery and identification of the etiologic agent. Specimen collection from appropriate sites is critical, as is the proper transport, storage, and processing of samples. Fungal elements seen by direct microscopy often provide the first clues to a fungal infection, and are the basis upon which empiric therapy is initiated. To ensure recovery of the fungus, a sufficient number and types of media should be utilized for primary isolation based upon the clinical history and the possible organisms expected. Accurate fungal identification, in combination with antifungal susceptibility testing, provides the basis for appropriate organism-directed antifungal therapy and is essential for conducting epidemiologic investigations.
Human and/or animal pathogens historically considered to be fungal are now placed in three kingdoms: Fungi, Straminipila (Stramenopila), containing the Oomycete Pythium, and Protoctista, with the bulk of the human pathogens in the kingdom Fungi. Organisms within this kingdom are eukaryotic (have cells containing a membrane-bound nucleus), heterotrophic (lack chlorophyll or other pigments capable of photosynthesis for making food, therefore must obtain nourishment from an external food source), may be unicellular or filamentous, and have cells surrounded by cell walls containing glucan, chitin, or both. Unlike animals, fungi possess cell walls, but unlike plants, the major cell wall component is not cellulose. In the past, medical problems attributed to these organisms, in comparison to those caused by the bacteria, viruses, and parasites, have been relatively few, and included allergic symptoms, mushroom poisoning, mycotoxicoses from the ingested fungal toxins, and occasional fungal infections. However, with the advent of modern medical advances utilizing immunosuppressive regimens, and with an increase in diseases/underlying conditions significantly altering the human immune system, fungal infections (mycoses) have increased significantly over the past couple decades. The recovery of these organisms from host tissue and their identification is often critical to the diagnosis and treatment of mycotic disease and is the classic method for documentation of pathogenicity. Histopathology and other adjunctive tools, such as antigen or antibody assays and molecular techniques, addressed elsewhere in this text, may also be relied upon for empiric/preemptive therapeutic decisions, when cultures are either not available or fail to provide unequivocal information. The proper collection, transport, and processing of specimens; selection of fungal stains and preliminary direct microscopy techniques; and use of appropriate media and incubation conditions are all important to the accurate identification of fungal infection. This chapter provides a cursory review of the laboratory fundamentals as they relate to medical mycology. It also reviews basic taxonomy, classification, and nomenclature regarding the kingdom Fungi and changes resulting from the Melbourne Code implemented in January 2013. Also included are descriptions of mycologic terms/features common to the most frequently recovered etiologic agents in the teleomorphic (sexual) phyla Ascomycota, Basidiomycota, and Glomeromycota (formerly Zygomycota) as well as those seen in the anamorphic (asexual) fungi. Fungi without known sexual states are referred to as “mitosporic” (based upon their reproductive mitotic processes). The mitosporic fungi are the most common etiologic agents of human and animal disease.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Fungal specimens
- Specimen collection
- Processing fungal specimens
- Direct microscopy
- Fungal taxonomy
- Fungal media
- Fungal identification
Introduction
The mycology laboratory plays a vital role in the diagnosis of fungal infections through the recovery and identification of the etiologic agent. Specimen collection from appropriate sites is critical, as is the proper transport, storage, and processing of samples. Fungal elements seen by direct microscopy often provide the first clues to a fungal infection, and are the basis upon which empiric therapy is initiated. To ensure recovery of the fungus, a sufficient number and type of media should be utilized for primary isolation based upon the clinical history and the possible organisms expected. Accurate fungal identification, in combination with antifungal susceptibility testing, provides the basis for appropriate organism-directed antifungal therapy and is essential for conducting epidemiologic investigations.
Human and/or animal pathogens historically considered to be fungal are now placed in three kingdoms: Fungi, Straminipila (Stramenopila), containing the Oomycete Pythium [1], and Protoctista, with the bulk of the human pathogens in the kingdom Fungi [2]. Organisms within this kingdom are eukaryotic (have cells containing a membrane-bound nucleus), heterotrophic (lack chlorophyll or other pigments capable of photosynthesis for making food, therefore must obtain nourishment from an external food source), may be unicellular or filamentous, and have cells surrounded by cell walls containing glucan, chitin, or both. Unlike animals, fungi possess cell walls, but unlike plants, the major cell wall component is not cellulose. In the past, medical problems attributed to these organisms, in comparison to those caused by the bacteria, viruses, and parasites, have been relatively few, and included allergic symptoms, mushroom poisoning, mycotoxicoses from ingested fungal toxins, and occasional fungal infections [2]. However, with the advent of modern medical advances utilizing immunosuppressive regimens, and with an increase in diseases/underlying conditions significantly altering the human immune system, fungal infections (mycoses) have increased significantly over the past couple decades. The recovery of these organisms from host tissue and their identification is often critical to the diagnosis and treatment of mycotic disease and is the classic method for documentation of pathogenicity. Histopathology, and other adjunctive tools, such as antigen or antibody assays and molecular techniques, addressed elsewhere in this text, may also be relied upon for empiric/preemptive therapeutic decisions, when cultures are either not available or fail to provide unequivocal information. The proper collection, transport, and processing of specimens; selection of fungal stains and preliminary direct microscopy techniques; and use of appropriate media and incubation conditions are all important to the accurate identification of fungal infection. This chapter provides a cursory review of the laboratory fundamentals as they relate to medical mycology. It also reviews basic taxonomy, classification, and nomenclature regarding the kingdom fungi and changes resulting from the Melbourne Code implemented in January 2013 [3]. Also included are descriptions of mycologic terms/features common to the most frequently recovered etiologic agents in the teleomorphic (sexual) phyla Ascomycota, Basidiomycota, and Glomeromycota (formerly Zygomycota) [4] as well as those seen in the anamorphic (asexual) fungi. Fungi without known sexual states are referred to as “mitosporic” (based upon their reproductive mitotic processes). The mitosporic fungi are the most common etiologic agents of human and animal disease.
Specimen Collection, Transport, and Processing
The likelihood of recovering a fungal etiologic agent is directly proportional to the quality of methods employed in the collection, transport, and processing of clinical specimens, and with the 2012 publication of Principles and Procedures for Detection of Fungi in Clinical Specimens—Direct Examination and Culture: Approved Guideline, M54-A, by the Clinical and Laboratory Standards Institute (CLSI), this information is now condensed into a readily available and user-friendly document addressing all aspects of these processes for the improved recovery of fungal isolates [5]. For all disease processes, recovery is highest from an active site of infection. Common (but not all inclusive) specimen types include those from the respiratory tract [6], draining sites, aspirated abscess fluids, normally sterile body fluids, urine [7], vaginal secretions [8], corneal scrapings [9], surgical tissue specimens, intravenous catheter tips (obtained by the Maki roll method [10]), and various surgically removed medical devices [11]. Although tissue may be homogenized for the recovery of Histoplasma capsulatum, when the patient history suggests infection with a member of the Mucorales or other filamentous fungi, tissue grinding should be avoided as it may be deleterious to the growth in culture of fragile fungal hyphae [4, 11]. Specimens peripheral to the site of infection, such as blood or bone marrow, may be diagnostic in disseminated disease or when foci are not easily accessible. Several blood culture systems reliably recover yeast pathogens [12]. If manual blood cultures are used, consider a broth/agar biphasic system in which an agar paddle is attached to the bottle (Septi-Chek, BD Diagnostic Systems, Sparks, MD). Several automated, continuously monitored blood culture systems are available with instruments designed and scalable for both high- and small-volume laboratories. These include the VersaTREK (Trek Diagnostic Systems/Thermo Scientific, Cleveland, Ohio), BacT/Alert (bio Mérieux, Durham, NC), and BACTEC (BD Diagnostic Systems, Sparks, MD) systems [13–19]. Always follow manufacturer’s recommendations for the specific system, using the maximum amount of blood samples recommended. The ratio of blood to broth is the most critical factor in fungal recovery, and should be near 1:5 in most systems [20]. Lysis centrifugation methods, either commercially available as the Isolator™ system (Alere, Waltham, MA) or manual methods [21, 22], are recommended for dimorphic fungal pathogens and filamentous fungi [23, 24]. Intravascular catheter tips are also frequently submitted, and should be cultured according to the semiquantitative method of Maki [10]. Blood cultures should also be drawn at the time of catheter removal to correlate catheter colony counts and organisms recovered with catheter-related septicemia. Catheter colony counts of less than 15 are less likely to be associated with infection. Specimens should be maintained at room temperature and transported to the laboratory as soon as possible, ideally within 2 h. Exceptions include storage of central nervous system specimens at 30 °C, and 4 °C extended storage for specimens likely to have bacterial contamination. Hair, skin, and nails may be transported in clean paper envelopes. Several sources provide specific guidelines for the collection, transport, and processing of various types of specimens for fungal culture [5, 11, 25, 26]. See Table 2.1 for common collection sites and consult Appendix A in the CLSI M54-A document [5] for more detailed information/procedures.
Prior to receipt in the mycology laboratory, a portion of all tissue samples submitted for culture should also be placed in formalin for submission to the histology laboratory. Histopathologic examination together with appropriate stains are usually necessary to document fungal invasion. These may include the routine hematoxylin and eosin (H&E) stain, Gomori methenamine silver (GMS) stain, periodic acid–Schiff (PAS) stain, and others. Discussion of the use of histopathology and of mycological stains is found in Chap. 4 of this book. See also Appendix C of the CLSI M54-A document [5]. As a part of routine processing, the mycology laboratory should also examine a portion of the specimen directly by microscopy, typically with the use of a potassium hydroxide (KOH) preparation, gram stain, calcofluor white fluorescent stain, India ink stain (limited to cerebrospinal fluid examination for Cryptococcus neoformans), or some other method (Table 2.2). Observation of fungal structures by direct microscopy and/or histopathology is essential to corroborate organism recovery in culture (rule out contamination). Table 9.4 in Sect. 9.1.1 of the CLSI M54-A document [5] provides a useful listing/description of yeasts and yeast-like fungi seen in clinical specimens.
The media used for primary isolation may vary according to personal preferences; however, certain basic tenets apply to all media used for primary recovery. Material from nonsterile sites should be cultured on media that will support fungal growth but also inhibit bacteria. Antibacterial agents, alone or in combination, are added for this purpose. Common choices include chloramphenicol (< 16 µg/ml), gentamicin (5–100 µg/ml), penicillin (20 µg/ml), streptomycin (40 µg/ml), and ciprofloxacin (5 µg/ml). These agents should not be included, however, when actinomycetes are suspected. Media may also be made selective by the addition of the eukaryotic protein synthesis inhibitor cycloheximide at 0.5 µg/ml. This may be useful in the detection of dimorphic fungi and dermatophytes; however, many clinically significant saprobic fungi may be suppressed, leading to failure in recovering opportunistic etiologic agents in compromised hosts. Therefore, media with and without this agent should routinely be employed. Enriched media with 5–10 %, sheep erythrocytes may be incorporated into the battery for fastidious thermally dimorphic fungi such as H. capsulatum and Blastomyces dermatitidis. Peptone-based versus plant-based media may also be a consideration. Many of the opportunistic filamentous fungi prefer plant-based media, producing more typical colony morphologies and more diagnostic structures, thus increasing the potential to make identification possible from primary plates. Plant-based media may also be made selective with antibacterial agents or cycloheximide. Table 2.3 lists several commercially available media that may be used for both primary isolation and identification. Please consult Sects. 10.2 and 10.3 in the CLSI M54-A document for additional information [5]. The choice of tubed versus plated media is made based upon space constraints, personal preference, and safety. The greater surface area provided by plates is preferred by many laboratorians (and always preferred by the fungi!), as manipulation of cultures, isolation procedures, etc. are more easily performed on plates. When used, plate lids should be firmly attached with an air-permeable material or plates sealed in air-permeable bags to avoid cross-contamination or laboratory worker exposure.
Optimally, cultures should be incubated at 30 °C (± 1 °C). If this temperature is not available, room temperature near 25 °C should be used. Seven-day incubation is generally adequate when screening for yeasts from oropharyngeal or vaginal sites. Although 4-week incubation times have been traditionally recommended, studies suggest that 3 weeks are adequate to detect fungal growth from most other specimens, excluding those from skin, hair, and nails, and in cultures requested specifically to attempt to recover dimorphic pathogens [27]. The time required for development of diagnostic structures, particularly for some coelomycetes and ascomycetes, may be considerably longer, up to several weeks [28, 29].
Examining Cultures
One recommendation for culture examination is every day for the first 3 days and twice a week thereafter. Alternate reading schedules can be found in the CLSI M54-A document, Sect. 11.1 [5], depending upon the source of the isolate. Cultures of yeasts are typically creamy to waxy, while moulds appear velvety to woolly to cottony. Some safety precautions common to both yeasts and moulds include the careful handling of plates and tubes so as not to create aerosols of infectious material and the prevention of contamination of patient cultures with ubiquitous fungi from the work surroundings.
Phenotypic Yeast and Yeastlike Organism Identification
Yeast cultures, consisting of unicellular organism that replicate by budding, may be handled on the open bench, adhering to the same safety precautions as for bacteria. Yeast and yeastlike fungi should be examined for their colony color (white to cream to pink; brownish-black for the yeast synanamorph of Exophiala species when observed on Sabouraud dextrose agar; blue to green to pink for Candida species on CHROMagar Candida™ (CHROMagar Microbiology, Paris, France)), growth rate, temperature requirements (or preferences), macroscopic morphology (smooth, wrinkled, glabrous, moist, dry, etc.), and microscopic morphology (size and shape, presence of blastoconidia, capsules, germ tubes, pseudohyphae, true hyphae, chlamydoconidia, etc.). Yeast morphology is most reliably observed on a cornmeal agar plate using the Dalmau method [30]. This technique involves streaking a very small amount of yeast onto a plate in two parallel lines, streaking back and forth over these lines for better isolation, and covering the area with a flame-sterilized coverslip. The plate is incubated at room temperature for 18–24 h and then examined microscopically for diagnostic structures. Tease mounts may also provide useful information. Additional procedures that may be required for the identification of yeasts include the reduction of nitrate to nitrite, urease activity, the ability of the organism to grow on media containing cycloheximide, and assimilation and fermentation patterns. Many commercial systems, both manual and automated, are available to assist in yeast identification.
Phenotypic Mould Identification
Any filamentous organisms recovered on culture should be examined and manipulated in a biological safety cabinet. While moulds can be recovered on a variety of media, conidiation/sporulation is generally enhanced on plant-based media. If not used in primary isolation, plant-based media should be employed in the identification process. Moulds should be examined for their growth rate, temperature requirements, and macroscopic morphology to include color (hyaline to brightly colored or phaeoid (brownish to blackish)), texture (velvety, woolly, granular, cottony, etc.), and the observation of any diagnostic features visible to the naked eye. The microscopic detail may be studied using tease mounts or temporary tape mounts (clear tape only) in lactophenol cotton blue. The preferred technique to demonstrate diagnostic structures and methods of conidiogenesis for most filamentous fungi is the slide-culture method. Additionally, this method can provide a permanent mount that can be preserved in a slide collection for future studies and is extremely useful for comparison with other similar isolates or atypical strains. Members of the order Mucorales (which includes Rhizopus, Lichtheimia (formerly Absidia), Mucor, and several other genera) may rapidly overgrow slide cultures, making this method less than optimal for studying these fungi.
Slide cultures should also not be set up on Moulds where the clinical history suggests a dimorphic pathogen such as H. capsulatum, B. dermatitidis, Coccidioides species, Paracoccidioides brasiliensis (not commonly seen in the USA), or Talaromyces (Penicillium) marneffei (usually restricted to HIV-infected individuals from endemic areas of Southeast Asia) [31]. Tease mounts should be prepared for these isolates in a mounting fluid known to kill the fungus, such as lactophenol cotton blue. Sporothrix schenckii, and other Sporothrix spp. [32], also dimorphic organisms, pose less of an exposure risk, and may be examined by slide culture. H. capsulatum and B. dermatitidis may be definitively identified using the DNA Gen-Probe® (AccuProbe, San Diego, CA) methodology. This method, which confirms a Coccidioides species, does not, however, differentiate between Coccidioides immitis and Coccidioides posadasii.
Molecular Fungal Identification
While this work contains a chapter on diagnostic molecular biology (Chap. 3), information about fungal identification would be incomplete without brief mention here of the most commonly used molecular method for the identification of clinical isolates. The method most often cited is sequencing with identification of the isolates by comparative sequence analysis [33–35]. Briefly, genomic DNA is extracted, an optimal gene target is amplified and sequenced, and the data are aligned and analyzed. The most common targets useful for a wide range of fungi are within the ribosomal DNA (rDNA) and include the internal transcribed spacer (ITS1 and ITS2) regions and the D1/D2 regions of the large ribosomal subunit. Sequence results are then compared against type strains or other credible deposits in a database using the BLASTn algorithm. GenBank is a commonly used database; however, it is non-curated, so there is no assurance that the sequence data deposited is from a correctly identified isolate, thus making it imperative that the molecular identification is compatible with the phenotypic features. While the ITS and D1/D2 regions are very useful, additional targets may be needed for some genera such as beta-tubulin (TUB), calmodulin (CAL), actin (ACT), CO1 (the mitochondrial cyctochrome oxidase 1 gene), the translation elongation factor (TEF), and others [36]. Other databases that are curated such as those at the Centraalbureau voor Schimmelcultures (CBS) and the online Fusarium database [37] are often necessary for a definitive identification. In light of cost containment and the dwindling number of individuals trained in classical morphologic identification, more laboratories are considering adding the sequencing of isolates in conjunction with phenotypic methods or as a stand-alone method. It should be noted that sequence-alone identification of limited or noninformative targets without a comparison of the phenotypic features has the potential for misidentification of isolates that could negatively impact patient management [36].
Taxonomy, Classification, and Nomenclature
Many volumes have been dedicated to the taxonomy, classification, and nomenclature of clinically significant fungi. Herein, this work only highlights some of the basic concepts. The classification scheme accepted by most authorities will be presented for the kingdom fungi. The term classification, in the fungal sense, refers to the application of names for the categories into which the taxa (taxonomic groups) may be grouped, with some subdivisions regarding their relative order. “Taxonomy” refers to this classification in a very systematic way, and nomenclature is the assigning of names to fungi. These processes, previously regulated by the rules of the International Code of Botanical Nomenclature (ICBN), are now under the auspices of the International Code of Nomenclature for algae, fungi, and plants. The Melbourne Code, adopted in 2011, and published in 2012 [3, 38], resulted in major changes which became effective January 1, 2013. Some of the most significants are as follows: (a) the abolishment of Article 59 of the previous ICBN, permitting multiple names for the same organism (such as one name for the anamorph and one for the teleomorph, i.e., such as the use of both Aspergillus fumigatus and Neosartorya fumigata); (b) the need to determine which name will be used (an ongoing process); and (c) the deposition of isolate information into a recognized repository for the valid publication of a fungal name. The following is an abbreviated classification scheme for the kingdom Fungi:
Group | Group Ending |
---|---|
Kingdom | none |
Subkingdom | none |
Phylum | mycota |
Subphylum | mycotina |
Class | mycetes |
Order | ales |
Family | aceae |
Genus | no specific ending |
Species | no specific ending |
Variety | no specific ending |
The phyla in which the sexual or teleomorph forms of the majority of human/animal pathogens reside are the Ascomycota, Basidiomycota and the Glomeromycota (formerly the Zygomycota) [4]. An example of this classification scheme for the ascomycete, Microascus cinereus, recovered from lower respiratory sites [39], would look like this:
Kingdom | Fungi |
---|---|
Subkingdom | Dikarya |
Phylum | Ascomycota |
Subphylum | Ascomycotina |
Order | Microascales |
Family | Microascaceae |
Genus | Microascus |
Species | Microascus cinereus |
M. cinereus, a sexual fungus (or the teleomorph) that produces perithecia, asci, and ascospores in culture also simultaneously produces an asexual form (the anamorph) that is microscopically quite different. Asexual fungi, previously given the prefix “form” to the classification scheme, such as form-class, form-order, etc., are now commonly known as “mitosporic” fungi, or those reproducing my mitosis rather than meiosis. The anamorphic form of M. cinereus is the phaeoid fungus, Scopulariopsis cinereus [39]. Anamorphic fungi are identified mostly on the basis of their method of conidiogenesis (how they form their reproductive structures). Asexual reproductive propagules are referred to as conidia, hence, the term conidiogenesis. Sexual fungi are mostly identified based on the method they use to form their sexual reproductive propagules (e.g., ascospores, basidiospores). Not all taxonomists have agreed that we should apply different names to the anamorph and teleomorph of the same fungus, the holomorph, or “whole fungus”; however, this has been the practice until the implementation of the Melbourne Code. As mentioned above, multiple names will no longer be permitted; however, the determinations as to which name will be used for the various genera is still ongoing. One genus that does appear to retain its anamorphic name is Fusarium [40]. Adding to this confusion, some multiple fungi-produced anamorph forms, such as is seen with the fungus Pseudallescheria boydii. P. boydii is the teleomorph; Scedosporium boydii is the anamorph (previously thought to be S. apiospermum) [41], and they may also produce a Graphium synanamorph, or another anamorphic form of the “whole fungus.” Practically speaking, most etiologic agents are identified in the laboratory on the basis of structures formed by the anamorphic form of the fungus. Although many mitosporic fungi have known teleomorphs, most require two mating strains to produce the sexual form. These are referred to as heterothallic. A few clinically significant fungi require only one strain to produce the teleomorph, and these as considered homothallic. M. cinereus and P. boydii, cited above, are examples of homothallic fungi.
Fungal Identification
Yeast identification is performed in a manner similar to that for bacterial identification, and easily lends itself to various compartmentalized and automated methods that measure various physiologic characteristics. Mould identification, however, currently relies more upon the observation of macroscopic morphologies, such as color and colonial features, growth rate, temperature maximums and minimums, and microscopic structures. Some of these more common identifying characteristics are exemplified in the organisms chosen in the thumbnail sketch of the kingdom fungi as illustrated in Table 2.4.
Ascomycota
Under the phylum Ascomycota, the ascomycetous yeasts are usually identified by yeast methods, while the Mould are identified based upon the structures they produce. Some of the filamentous homothallic ascomycetes produce ascomata known as cleistothecia, perithecia, or gymnothecia in which the asci and ascospores are contained (Figs. 2.1–2.4).
Basidiomycota
Similarly, the red and white yeasts within the phylum Basidiomycota are commonly identified by yeast methodologies. The filamentous basidiomycetes pose identification dilemmas, as they frequently remain sterile in culture, producing no unique reproductive structures. Schizophyllum commune is one of the few that may sometimes be tentatively identified by its production of spicules along the sides of the hyphae, and occasionally by clamp connections (Fig. 2.5), basidiocarps, and basidiospores (Fig. 2.6) when dikaryons (compartments of a hypha that contain two nuclei, each derived from a different parent) are present.
Glomeromycota
Human and animal pathogens in the phylum Glomeromycota (formerly Zygomycota) are contained within the subphyla incertae sedis Mucoromycotina containing the order Mucorales [42], and Entomophthoromycotina containing the order Entomophthorales. In the order, Mucorales are the most common mucoralean genera such as Rhizopus (Fig. 2.7), Mucor, Lichtheimia (formerly Absidia) [43], Rhizomucor, Cunninghamella, and Cokeromyces (Fig. 2.8), while the Entomophthorales encompass the less frequently seen genera Conidiobolus (Fig. 2.9) and Basidiobolus (both characterized by forcibly discharged conidia).
Mitosporic Fungi
The group that contains the most human etiologic agents, by far, is one known as the “mitosporic fungi,” or previously, the “fungi imperfecti.” While these fungi may by connected to various sexual phyla, this association has not been yet demonstrated, and therefore these fungi are identified on the basis of their asexual rather than sexual reproductive propagules (method of conidial formation or conidiogenesis). Two main groups exist within the mitosporic fungi. The hyphomycetes bear their conidia free to the air, while the coelomycetes have their conidia contained within some type of enclosed to semi-enclosed structure [28, 29]. The hyphomycetes contain numerous common moniliaceous (hyaline) and phaeoid or dematiaceous (dark) genera and generally produce their conidia by either blastic or thallic methods. Blastic conidia are “blown out” of some type of conidiogenous cell. These include those produced from phialides, as in Phialophora species (Fig. 2.10) or Aspergillus species such as Aspergillus flavus (Fig. 2.11), or from annellides, as in Scopulariopsis cirrosus (Fig. 2.12). Some species blow out their conidia through pores, such as in Curvularia (formerly Bipolaris) hawaiiensis [44] (Fig. 2.13). Thallic conidia are formed from preexisting hyphae, as in Coccidioides species (Fig. 2.14), Malbranchea species, and Neoscytalidium (formerly Scytalidium) dimidiatum [45] (Fig. 2.15). The structures produced by coelomycetes to contain their conidia are known as conidioma (sing.) or conidiomata (pl.). They may be round structures with an opening or ostiole known as a pycnidium, as in Phoma species (Fig. 2.16), or a flat, cup-shaped, semi-enclosed structure known as an acervulus. The conidiogenous cells within both of these conidiomata may be either phialidic or annellidic. A recent review highlights coelomycete fungi seen in the clinical laboratory and salient features for their identification [29].
References
Mendoza L, Vilela R. The mammalian pathogenic Oomycetes. Curr Fungal Infect Rep. 2013; DOI 10.1007/s12281-013-0144-z.
Howard DH. An introduction to the taxonomy of zoopathogenic fungi. In: Howard DH, editor. Pathogenic fungi in humans and animals. vol. 16, 2nd Ed. New York: Marcel Dekker, Inc.; 2003. pp. 1–16.
International Code of Nomenclature for algae, fungi, and plants (Melbourne Code). Adopted by the Eighteenth International Botanical Congress, Melbourne, Australia, July 2011. Prepared and edited by McNeill J et al. Regnum Vegetabile 154. Koeltz Scientific Books; 2012. (ISBN 978-3-87429-425–6)
Hibbert DS, Binder M, Fischoff JF, Blackwell M, et al. A higher-level classification of the Fungi. Mycol Res. 2007;111:509–47.
CLSI. Principles and procedures for detection of fungi in clinical specimens—direct examination and culture: approved guideline. Wayne: Clinical and Laboratory Standards Institute; 2012. (CLSI document M54-A)
Bartlett JG, Ryan KJ, Smith TF, Wilson WR. Cumitech 7A. Laboratory diagnosis of lower respiratory tract infections. Washington II JA, Coordinating ed. Washington: American Society of Microbiology; 1987.
Clarridge J, Pezzlo MT, Vosti KL. Cumitech 2A. Laboratory diagnosis of urinary tract infections. Weissfeld AW, coordinating ed. Washington: American Society for Microbiology; 1987.
Eschenbach D, Pollock HM, Schacter J Cumitech 17. Laboratory diagnosis of female genital tracts infections. Rubin SJ, coordinating ed. Washington: American Society for Microbiology; 1983.
Jones DB, Liesegang TJ, Robinson NM. Cumitech 13. Laboratory diagnosis of ocular infections. Washington JA, coordinating ed. Washington: American Society for Microbiology; 1981.
Maki DG, Weise CD, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296:1303–9.
McGowan KL. Specimen collection, transport, and processing: mycology. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of clinical microbiology. 10th Ed. Washington: ASM Press; 2011. pp. 1756–66.
CLSI. Principles and Procedures for Blood Cultures; Approved Guideline. CLSI document M47-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2007
Jorgensen JH, Mirrett S, McDonald LC, et al. Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAM medium for detection of bacteremia and fungemia. J Clin Microbiol. 1997;35:53–8.
Mattia AR. FDA review criteria for blood culture systems. Clin Microbiol Newsl. 1993;15:132–6.
Horvath LL, George BJ, Murray CK, Harrison LS, Hospenthal DR. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J Clin Microbiol. 2004;42:115–8.
Horvath LL, Hospenthal DR, Murray CK, Dooley DP. Detection of simulated candidemia by the BACTEC 9240 system with plus aerobic/F and anaerobic/F blood culture bottles. J Clin Microbiol. 2003;41:4714–7.
Horvath LL, Hospenthal DR, Murray CK, Dooley DP. Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida. J Clin Microbiol. 2003;41:2629–32.
McDonald LC, Weinstein MP, Fune J, Mirrett S, Reimer LG, Reller LB. Controlled comparison of BacT/ALERT FAN aerobic medium and BACTEC fungal blood culture medium for detection of fungemia. J Clin Microbiol. 2004;39:622–4.
Meyer M-H, Letscher-Bru V, Jaulhac B, Waller J, Candolfi E. Comparison of Mycosis IC/F and plus aerobic/F media for diagnosis of fungemia by the BACTEC 9240 system. J Clin Microbiol. 2004;42:773–7.
Auckenthaler R, Ilstrup DM, Washington JA II. Comparison of recovery of organisms from blood cultures diluted 10 % (volume/volume) and 20 % (volume/volume). J Clin Microbiol. 1982;15:860–4.
Billi J, Stockman L, Roberts GD, Horstmeier CD, Istrup DM. Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood. J Clin Microbiol. 1983;18:469–71.
Bille J, Edson RS, Roberts GD. Clinical evaluation of the lysis-centrifugation blood culture system for detection of fungemia and comparison with a conventional biphasic broth blood culture system. J Clin Microbiol. 1984;19:126–8.
Guerra-Romero L, Edson RC, Dockerill FR, Horstmeier CD, Roberts GD. Comparison of Du Pont Isolator and Roche Septi-check for detection of fungemia. J Clin Microbial. 1987;25:1623–5.
Lyon R, Woods G. Comparison of the BacT/Alert and ISOLATOR blood culture systems for recovery of fungi. Am J Clin Pathol. 1995;103:660–2.
Hazen KC. Mycology and aerobic actinomycetes. In: Isenberg HD, ed. Essential procedures for clinical microbiology. Washington: American Society for Microbiology; 1998. pp. 255–283.
Miller JM. A guide to specimen management in clinical microbiology. 2nd Ed. Washington: American Society for Microbiology Press; 1999.
Labarca JAI, Wagar EA, Grasmick AE, Kokkinos HM, Bruckner DA. Critical evaluation of a 4-week incubation for fungal cultures: is the fourth week useful? J Clin Microbiol. 1998;36:3683–5.
Sutton DA. Coelomycetous fungi in human disease. A review: clinical entities, pathogenesis, identification and therapy. Rev Iberoam Micol. 1999;16:171–9.
Stchigel AM, Sutton DA. Coleomycete fungi in the clinical lab. Curr Fungal Infect Rep. 2013;7:171–91.
McGinnis MR. Laboratory handbook of medical mycology. New York: Academic Press; 1980.
Samson RA, Yilmaz N, Houbraken J, Spierenburg H, Seifert K, Peterson SW, Varga J, Frisvad JC. Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium. Stud Mycol. 2011;70:159–83.
Marimon R, Cano J, Gené J, Sutton DA, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol. 2007;45:3198–206.
Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, Lafe K, Bui U, Limaye AP, Cookson BT. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol. 2001;39:4042–51.
Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol. 1997;35:1216–23.
Glass NL, Donaldson GC. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol. 1995;61:1323–30.
Sutton DA, Thompson EH, Fothergill AW, Wiederhold NP. Mould identification by ITS rDNA sequencing: ready for prime time in the routine lab? Abstract M-1381 of the 53rd Interscience Conference on antimicrobial agents and chemotherapy, Sept 19, 2013, Denver, CO.
O’Donnell K, Sutton DA, Rinaldi MG, Sarver BAJ, et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol. 2010;48:3708–18.
Hawksworth DL, Crous PW, Redhead SA, et al. The Amsterdam Declaration on fungal nomenclature. IMA Fungus. 2011;2:105–12.
Sandoval-Denis M, Sutton DA, Fothergill AW, Cano-Lira J, Decock CA, de Hoog GS, Guarro J. Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs. J Clin Microbiol. 2013;51:3937–43.
Geiser DM, Aoki T, Bacon CW, Baker SE, et al. One fungus, one name: defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology. 2013;103:400–8.
Gilgado F, Cano J, Gené J, Sutton DA, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol. 2008;46:766–71.
Hoffman K, Pawlowska J, Walther G, Wrzosek M, de Hoog GS, Benny GL, Kirk PM, Voigt K. The family structure of the Mucorales: a synoptic revision based on comprehensive multigene-genealogies. Persoonia. 2013;30:57–76.
Alastruey-Izquierdo A, Hoffman K, de Hoog GS, Ridriguez-Tudela JL, Voight K, Bibashi E, Walther G. Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus). J Clin Microbiol. 2010;48:2154–70.
Manamgoda DS, Cai L, McKenzie EHC, Crous PW, Madrid H, Chukeatirote E, Shivas RG, Tan YP, Hyde KD. A phylogenetic and taxonomic re-evaluation of the Bipolaris—Cochliobolus—Curvularia complex. Fungal Diversity. 2012;56:131–44.
Crous PW, Slippers B, Wingfield MJ, Rheeder J, Marasas WFO, Philips AJL, Alves A, Burgess T, Barber P, Groenewald JZ. Phylogenetic lineages in the Botryosphaeriaceae. Stud Mycol. 2006;55:235–53.
Suggested Reading
Chandler FW, Watts JC. Pathologic diagnosis of fungal infections. Chicago: American Society of Clinical Pathologists Press; 1987.
deHoog GS, Guarro J, Gene J, Figueras MJ. Atlas of clinical fungi, 2nd Ed. Utrecht: Centraalbureau voor Schimmelcultures; 2000.
Larone DH. Medically important fungi: a guide to identification, 5th Ed. Washington, DC: American Society for Microbiology Press; 2011.
Mandell GL, Diamond RD (eds). Atlas of fungal infections, (Atlas of infectious diseases). Philadelphia: Current Medicine; 2000.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sutton, D. (2015). Basic Mycology. In: Hospenthal, D., Rinaldi, M. (eds) Diagnosis and Treatment of Fungal Infections. Infectious Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-13090-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-13090-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13089-7
Online ISBN: 978-3-319-13090-3
eBook Packages: MedicineMedicine (R0)